Prosecution Insights
Last updated: April 19, 2026

Medytox Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18709913 BOTULINUM NEUROTOXIN COMPOSITION MONSHIPOURI, MARYAM 1651 Non-Final OA May 14, 2024
17995428 BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT FACILITATES DISCHARGE RATE CONTROL AND IS STABLE STIGELL, THEODORE J 3783 Final Rejection Oct 04, 2022

Managing Medytox Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month